부산대학교 도서관

Duijsens, D.; Staes, E.; Segers, M.; Michels, D.; Pälchen, K.; Hendrickx, M.E.; Verkempinck, S.H.E.; Grauwet, T.

In Food Chemistry 1 October 2024 454

Duijsens, D.; Alfie Castillo, A.I.; Verkempinck, S.H.E.; Pälchen, K.; Hendrickx, M.E.; Grauwet, T.

In Food Chemistry 15 October 2023 423

Duijsens, D.; Pälchen, K.; De Coster, A.; Verkempinck, S.H.E.; Hendrickx, M.E.; Grauwet, T.

In Food Research International August 2022 158

Verkempinck, S.H.E.; Duijsens, D.; Michels, D.; Guevara-Zambrano, J.M.; Infantes-Garcia, M.R.; Pälchen, K.; Grauwet, T.

In Food Research International June 2022 156

Grauwet K; Cellular Immunotherapy Program, Krantz Family Center for Cancer Research, Massachusetts General Hosptial, Charlestown, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.; Berger T; Cellular Immunotherapy Program, Krantz Family Center for Cancer Research, Massachusetts General Hosptial, Charlestown, Massachusetts, USA.; Kann MC; Cellular Immunotherapy Program, Krantz Family Center for Cancer Research, Massachusetts General Hosptial, Charlestown, Massachusetts, USA.; Silva H; Cellular Immunotherapy Program, Krantz Family Center for Cancer Research, Massachusetts General Hosptial, Charlestown, Massachusetts, USA.; Larson R; Cellular Immunotherapy Program, Krantz Family Center for Cancer Research, Massachusetts General Hosptial, Charlestown, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.; Leick MB; Cellular Immunotherapy Program, Krantz Family Center for Cancer Research, Massachusetts General Hosptial, Charlestown, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.; Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA.; Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.; Bailey SR; Cellular Immunotherapy Program, Krantz Family Center for Cancer Research, Massachusetts General Hosptial, Charlestown, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.; Bouffard AA; Cellular Immunotherapy Program, Krantz Family Center for Cancer Research, Massachusetts General Hosptial, Charlestown, Massachusetts, USA.; Millar D; Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA.; Gallagher K; Cellular Immunotherapy Program, Krantz Family Center for Cancer Research, Massachusetts General Hosptial, Charlestown, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.; Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts, USA.; Turtle CJ; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.; Department of Medicine, University of Washington, Seattle, Washington, USA.; Frigault MJ; Cellular Immunotherapy Program, Krantz Family Center for Cancer Research, Massachusetts General Hosptial, Charlestown, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.; Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA.; Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.; Maus MV; Cellular Immunotherapy Program, Krantz Family Center for Cancer Research, Massachusetts General Hosptial, Charlestown, Massachusetts, USA mvmaus@mgh.harvard.edu.; Harvard Medical School, Boston, Massachusetts, USA.; Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA.; Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.

Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

Wehrli M; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Guinn S; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland.; Cancer Convergence Institute and Bloomberg Kimmel Institute at Johns Hopkins, University, Baltimore, Maryland.; Birocchi F; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Kuo A; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Sun Y; Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Larson RC; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Almazan AJ; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Scarfò I; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Bouffard AA; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Bailey SR; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Anekal PV; MicRoN Core, Harvard Medical School, Boston, Massachusetts.; Montero Llopis P; MicRoN Core, Harvard Medical School, Boston, Massachusetts.; Nieman LT; Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Song Y; Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Xu KH; Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Berger TR; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Kann MC; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Leick MB; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Blood and Marrow Transplant Program, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Silva H; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Salas-Benito D; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Kienka T; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Grauwet K; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Armstrong TD; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland.; Cancer Convergence Institute and Bloomberg Kimmel Institute at Johns Hopkins, University, Baltimore, Maryland.; Zhang R; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland.; Cancer Convergence Institute and Bloomberg Kimmel Institute at Johns Hopkins, University, Baltimore, Maryland.; Zhu Q; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland.; Cancer Convergence Institute and Bloomberg Kimmel Institute at Johns Hopkins, University, Baltimore, Maryland.; Fu J; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland.; Cancer Convergence Institute and Bloomberg Kimmel Institute at Johns Hopkins, University, Baltimore, Maryland.; Schmidts A; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Korell F; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Jan M; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.; Choi BD; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Department of Neurosurgery, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.; Liss AS; Division of Gastrointestinal and Oncologic Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Boland GM; Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Department of Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.; Ting DT; Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Burkhart RA; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland.; Cancer Convergence Institute and Bloomberg Kimmel Institute at Johns Hopkins, University, Baltimore, Maryland.; Jenkins RW; Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Zheng L; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland.; Cancer Convergence Institute and Bloomberg Kimmel Institute at Johns Hopkins, University, Baltimore, Maryland.; Jaffee EM; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland.; Cancer Convergence Institute and Bloomberg Kimmel Institute at Johns Hopkins, University, Baltimore, Maryland.; Zimmerman JW; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland.; Cancer Convergence Institute and Bloomberg Kimmel Institute at Johns Hopkins, University, Baltimore, Maryland.; Maus MV; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Blood and Marrow Transplant Program, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.

Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

Leick MB; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA 02129, USA; Harvard Medical School, Boston, MA 02115, USA; Blood and Marrow Transplant Program, Massachusetts General Hospital, Boston, MA 02114, USA.; Silva H; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA 02129, USA.; Scarfò I; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA 02129, USA; Harvard Medical School, Boston, MA 02115, USA.; Larson R; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA 02129, USA; Harvard Medical School, Boston, MA 02115, USA.; Choi BD; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA 02129, USA; Harvard Medical School, Boston, MA 02115, USA; Department of Neurosurgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA.; Bouffard AA; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA 02129, USA.; Gallagher K; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA 02129, USA; Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA.; Schmidts A; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA 02129, USA; Harvard Medical School, Boston, MA 02115, USA.; Bailey SR; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA 02129, USA; Harvard Medical School, Boston, MA 02115, USA.; Kann MC; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA 02129, USA.; Jan M; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA 02129, USA; Harvard Medical School, Boston, MA 02115, USA; Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA.; Wehrli M; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA 02129, USA.; Grauwet K; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA 02129, USA.; Horick N; Department of Biostatistics, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA.; Frigault MJ; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA 02129, USA; Harvard Medical School, Boston, MA 02115, USA; Blood and Marrow Transplant Program, Massachusetts General Hospital, Boston, MA 02114, USA.; Maus MV; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA 02129, USA; Harvard Medical School, Boston, MA 02115, USA; Blood and Marrow Transplant Program, Massachusetts General Hospital, Boston, MA 02114, USA. Electronic address: mvmaus@mgh.harvard.edu.

Publisher: Cell Press Country of Publication: United States NLM ID: 101130617 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-3686 (Electronic) Linking ISSN: 15356108 NLM ISO Abbreviation: Cancer Cell Subsets: MEDLINE

Larson RC; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Cancer Center, Massachusetts General Hospital, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Kann MC; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA, USA.; Cancer Center, Massachusetts General Hospital, Boston, MA, USA.; Bailey SR; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Cancer Center, Massachusetts General Hospital, Boston, MA, USA.; Haradhvala NJ; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Harvard Graduate Program in Biophysics, Harvard University, Cambridge, MA, USA.; Llopis PM; MicRoN Core, Harvard Medical School, Boston, MA, USA.; Bouffard AA; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA, USA.; Cancer Center, Massachusetts General Hospital, Boston, MA, USA.; Scarfó I; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Cancer Center, Massachusetts General Hospital, Boston, MA, USA.; Leick MB; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Cancer Center, Massachusetts General Hospital, Boston, MA, USA.; Grauwet K; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Cancer Center, Massachusetts General Hospital, Boston, MA, USA.; Berger TR; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA, USA.; Cancer Center, Massachusetts General Hospital, Boston, MA, USA.; Stewart K; Cancer Center, Massachusetts General Hospital, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Anekal PV; MicRoN Core, Harvard Medical School, Boston, MA, USA.; Jan M; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Cancer Center, Massachusetts General Hospital, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Pathology, Massachusetts General Hospital, Boston, MA, USA.; Joung J; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Brain and Cognitive Science, MIT, Cambridge, MA, USA.; Department of Biological Engineering, MIT, Cambridge, MA, USA.; McGovern Institute for Brain Research at MIT, Cambridge, MA, USA.; Howard Hughes Medical Institute, MIT, Cambridge, MA, USA.; Schmidts A; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Cancer Center, Massachusetts General Hospital, Boston, MA, USA.; Ouspenskaia T; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Law T; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Regev A; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Biology and Koch Institute of Integrative Cancer Research, MIT, Cambridge, MA, USA.; Genentech, South San Francisco, CA, USA.; Getz G; Harvard Medical School, Boston, MA, USA.; Cancer Center, Massachusetts General Hospital, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Pathology, Massachusetts General Hospital, Boston, MA, USA.; Maus MV; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA, USA. mvmaus@mgh.harvard.edu.; Harvard Medical School, Boston, MA, USA. mvmaus@mgh.harvard.edu.; Cancer Center, Massachusetts General Hospital, Boston, MA, USA. mvmaus@mgh.harvard.edu.; Broad Institute of MIT and Harvard, Cambridge, MA, USA. mvmaus@mgh.harvard.edu.

Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-4687 (Electronic) Linking ISSN: 00280836 NLM ISO Abbreviation: Nature Subsets: MEDLINE

Gallagher KME; Immune Monitoring Laboratory, Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA.; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA.; Department of Pathology, Harvard Medical School, Boston, Massachusetts, USA.; Leick MB; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.; Larson RC; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.; Berger TR; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA.; Katsis K; Immune Monitoring Laboratory, Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA.; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA.; Yam JY; Immune Monitoring Laboratory, Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA.; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA.; Brini G; Immune Monitoring Laboratory, Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA.; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA.; Grauwet K; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.; Maus MV; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.

Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE

Trombetta, B.A.; Kandigian, S.E.; Webb, P.K.; Kuo, Y.; Ramirez, C.E.; El-Mufti, L.; Bolling, A.; Fortin, B.; Pardo, S.; Mukerji, S.S.; Carlyle, B.C.; Kitchen, R.R.; Miller, S.; Hazra, A.; Pandya, U.M.; Miller, G.A.; Grauwet, K.; Jennings, C.G.; Sweeney, T.; Jain, S.; Jarolim, P.; Gilboa, T.; Norman, M.; Ko, J.; Ahmad, Q.R.; Walt, D.R.; Davis, V.; Morrison-Smith, C.; Simmons, D.P.; Bedard, M.; Watts, G.; Gomez-Rivas, E.; Cunin, P.; Suliman, S.; Fink, C.; De León Peralta, E.J.; Ritterhouse, L.L.; De Silva, P.; Barilla, R.M.; Wang, J.; Ventresca, H.; Bates, S.; Nicholson, B.; Wong, E.; Kann, M.; Pleskow, H.; Zhou, W.; Kwock, M.; Cheng, L.; Toombs, J.A.; Yohannes, S.; Gay, R.; Slavik, J.; Larson, R.; Luo, N.M.; Samaha, C.; Zhou, S.; Ganhadeiro, Z.

In: BMC Infectious Diseases. (BMC Infectious Diseases, December 2021, 21(1))